CareSource Partners with Oncology Research Platform to Provide Members with Value-Based Cancer Care

(Dayton, OH – June 12, 2019) CareSource implemented Eviti® Connect from NantHealth, Inc, (NASDAQ: NH) on June 1.  Eviti Connect allows members to access the most up-to-date cancer regimens and research, as well more than 6,000 clinical trials. The online, evidence-based medicine library and clinical trials database within Eviti Connect helps oncologists find the best treatment options for members and obtain insurance authorization in real time. 

With Eviti Connect, CareSource will improve the quality of care provided to members and help oncologists provide the best treatment for members, reduce provider administrative burden and decrease the turnaround time for patients to receive care.  Another highlight of Eviti Connect for oncology providers includes the peer-support network in which oncologists can consult with each other about treatment options for their patients. 

“Having to wait for a doctor to get approval for treatment can be agonizing for cancer patients and researching cancer treatments can be overwhelming,” said Clayton Edwards, Senior Vice President of Pharmacy for CareSource. “Our providers will now be able to get authorization for drug treatment regimens in real-time, with more accuracy and efficiency, and our members will benefit from the most current, nationally recognized drug treatment for their type of cancer.”

“We are privileged to support CareSource in their mission to provide the most appropriate and latest evidence-based treatments to their members and the selection of NantHealth underscores the value that Eviti Connect brings to the market,” said Ron Louks, Chief Operating Officer of NantHealth. “Eviti Connect will help CareSource improve their claim processing efficiency, streamline the pre-authorization process for cancer treatments and reduce denials and appeals.  We expect this partnership to expand Eviti Connect’s total covered lives to over 25 million.”

About CareSource

CareSource is a nonprofit, multi-state health plan serving government programs, and is recognized as a national leader in managed care. Founded in 1989, CareSource administers one of the nation’s largest Medicaid managed care plans and offers a lifetime of access to care through health insurance, including Medicaid, Health Insurance Marketplace, Medicare Advantage and Dual-Eligible programs.

 Headquartered in Dayton, Ohio, CareSource serves nearly 2 million members in Georgia, Indiana, Kentucky, Ohio and West Virginia. CareSource understands the challenges consumers face navigating the health system and is transforming health care with industry-leading programs that improve the health and well-being of our members.

For more, visit www.caresource.com, follow @caresource on Twitter, or like CareSource on Facebook

About NantHealth

NantHealth, a member of the NantWorks ecosystem of companies, is a next-generation, personalized healthcare company that enables more effective treatment decisions for critical illnesses and improved patient outcomes by empowering clinical decision support and providing leading software-based solutions and services across the continuum of care for physicians, payers, patients and biopharmaceutical organizations. NantHealth enables the use of cutting edge data through advancements in technology and precision medicine to work towards the goal of optimizing patient outcomes and enabling value-based care. NantHealth’s comprehensive product portfolio combines the latest technology in payer/provider platforms that exchange information in near-real time (NaviNet and Eviti), solutions that deliver Medical Device Interoperability (MDI) (Connected Care) and in molecular analysis (GPS Cancer^® and Liquid GPS^®). NantHealth’s Eviti Connect streamlines the pre-authorization of cancer treatment through the online entry of treatment plans, eliminating phone calls to health plans, while reducing denials and appeals. For more information, please visit www.nanthealth.com and follow us on Twitter, Facebook and LinkedIn.